Longevity
NAD+
Also called NAD+, NMN
per administration
It has been used in people, but no trial has settled how much or how often.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 33.33mg/mL
- Volume per draw
- 3mL
- Units to dial
- 300
- Doses per cartridge
- 1
This is 300 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.
Dial range varies by pen; 1–60 units is the common configuration.
Vial label
Copy this into your label printer.
Published research contexts for NAD+ describe 100–500 mg per administration. Descriptive only, not a recommendation.
A cofactor rather than a peptide; its precursors turn over rapidly and a single decay figure does not describe it well.
A cofactor (nicotinamide adenine dinucleotide) and its precursor NMN, catalogued here because people group them with peptides though neither is one. Reported amounts vary widely by route — intravenous infusions, subcutaneous injections and oral precursors are all in circulation — and no single dose-ranging trial fixes a schedule, so the figure above is a nominal placeholder and no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- NAD+/NMN precursor literatureHuman work covers oral NMN and NR and intravenous NAD+ infusions; amounts vary by route and are not fixed by a dose-ranging trial.